The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery

Recruiting now · Phase 4

Conditions studied: Coronary Artery Disease, Atrial Fibrillation, Coronary Artery Bypass Grafting, Colchicine

In brief

Development of a new comprehensive method for perioperative prevention of atrial fibrillation paroxysms in cardiac surgery patients at the hospital stage. It is planned to recruit 70 patients who will undergo pericardial fenestration during the operation using the original technique during coronary artery bypass grafting (Patent No. 2647626 C1 Russian Federation), and will be prescribed colchicine (the drug "Colchicum-dispert") in the perioperative period in order to prevent the development of paroxysms of atrial fibrillation in the postoperative period, and 70 cardiac surgery patients operated on using the standard technique (without performing the pericardial fenestration procedure intraoperatively), receiving non-steroidal anti-inflammatory drugs in the postoperative period.

Key facts

Study ID
NCT06798714
Run by
Tomsk Cardiology Research Institute
People needed
140
Starts
2025-01-20
Expected to finish
2026-02-20
Last updated by the study team
2025-09-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.